Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon May 30, 2024 7:13pm
108 Views
Post# 36065438

RE:RE:RE:RE:Epidiolex generic approved by Jazz…our partner?

RE:RE:RE:RE:Epidiolex generic approved by Jazz…our partner?Mdj...for Keith to say they are preparing for epidiolex launch in the U.S and then to learn outta 14 pharmaceutical corps pagadis was granted manufacturing, marketing, approval by JAZZ for epidiolex generic tells me this is our partner...terms like the occurrence of other events will still be unknown but I feel strongly pagadis is our partner...supporting a Corp in a generic venture could be beneficial in the generic inevitability especially if your financially in on it as in assuming this patent foregoance wasn't a gift.  
<< Previous
Bullboard Posts
Next >>